title: Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.
authors: Department of Haematology/Oncology, National University Health System, Singapore, Singapore.
authors: Matthew S
authors: MS
authors: Davids
authors: Matthew
authors: M
authors: Davids
authors: Amanda
authors: A
authors: Charlton
authors: Swee-Siang
authors: SS
authors: Ng
authors: Mei-Ling
authors: ML
authors: Chong
authors: Kevin
authors: K
authors: Laubscher
authors: Mohammed
authors: M
authors: Dar
authors: Jeffrey
authors: J
authors: Hodge
authors: Richie
authors: R
authors: Soong
authors: Boon Cher
authors: BC
authors: Goh
mesh_terms: D000368:Aged; D001483:Base Sequence; D015415:Biomarkers / Q000378:metabolism; D015266:Carcinoma, Merkel Cell / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D004252:DNA Mutational Analysis; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007191:Indazoles; D007633:Keratins / Q000378:metabolism; D009154:Mutation; D009362:Neoplasm Metastasis; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; C400901:CAM 5.2 antigen; D007191:Indazoles; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D007633:Keratins; C516667:pazopanib; D020796:Receptor, Platelet-Derived Growth Factor alpha; D010751:Phosphopyruvate Hydratase